GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $59,000 | 0.0% | 1,361 | 0.0% | 0.01% | +9.1% |
| Q1 2022 | $59,000 | -1.7% | 1,361 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $60,000 | +13.2% | 1,361 | -2.7% | 0.01% | +10.0% |
| Q3 2021 | $53,000 | -5.4% | 1,399 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $56,000 | +12.0% | 1,399 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $50,000 | -2.0% | 1,399 | +0.6% | 0.01% | -9.1% |
| Q4 2020 | $51,000 | -13.6% | 1,391 | -11.1% | 0.01% | -21.4% |
| Q3 2020 | $59,000 | -7.8% | 1,565 | 0.0% | 0.01% | -6.7% |
| Q2 2020 | $64,000 | +8.5% | 1,565 | 0.0% | 0.02% | -6.2% |
| Q1 2020 | $59,000 | -20.3% | 1,565 | 0.0% | 0.02% | -15.8% |
| Q4 2019 | $74,000 | +19.4% | 1,565 | +7.4% | 0.02% | +11.8% |
| Q3 2019 | $62,000 | +6.9% | 1,457 | 0.0% | 0.02% | +6.2% |
| Q2 2019 | $58,000 | -4.9% | 1,457 | 0.0% | 0.02% | -5.9% |
| Q1 2019 | $61,000 | +8.9% | 1,457 | 0.0% | 0.02% | -5.6% |
| Q4 2018 | $56,000 | +12.0% | 1,457 | +16.0% | 0.02% | +5.9% |
| Q3 2018 | $50,000 | -77.5% | 1,256 | -77.2% | 0.02% | -80.0% |
| Q2 2018 | $222,000 | +3.3% | 5,504 | 0.0% | 0.08% | +6.2% |
| Q1 2018 | $215,000 | +7.0% | 5,504 | -2.7% | 0.08% | +14.3% |
| Q4 2017 | $201,000 | -47.4% | 5,656 | -39.8% | 0.07% | -46.2% |
| Q3 2017 | $382,000 | -10.7% | 9,402 | -5.3% | 0.13% | -15.6% |
| Q2 2017 | $428,000 | -10.8% | 9,926 | -12.8% | 0.15% | -15.8% |
| Q1 2017 | $480,000 | -10.6% | 11,377 | -18.3% | 0.18% | -25.9% |
| Q4 2016 | $537,000 | -26.9% | 13,932 | -18.2% | 0.25% | -35.0% |
| Q3 2016 | $735,000 | +3.1% | 17,035 | +3.5% | 0.38% | +2.4% |
| Q2 2016 | $713,000 | +7.9% | 16,457 | +1.0% | 0.37% | +4.8% |
| Q1 2016 | $661,000 | +1.8% | 16,300 | +1.4% | 0.35% | -7.3% |
| Q4 2015 | $649,000 | +22.5% | 16,077 | +16.6% | 0.38% | +19.0% |
| Q3 2015 | $530,000 | -9.9% | 13,787 | -2.4% | 0.32% | -3.3% |
| Q2 2015 | $588,000 | +8.1% | 14,129 | +19.8% | 0.33% | +3.8% |
| Q1 2015 | $544,000 | +1713.3% | 11,797 | +2033.3% | 0.32% | +1291.3% |
| Q4 2014 | $30,000 | – | 553 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |